These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13072832)

  • 1. Biologic variability of breast carcinoma in relation to diagnosis and therapy.
    BLACK MM; SPEER FD
    N Y State J Med; 1953 Jul; 53(13):1560-3. PubMed ID: 13072832
    [No Abstract]   [Full Text] [Related]  

  • 2. Some biologic considerations in the treatment of breast carcinoma.
    BLACK MM; SPEER FD
    N Y State J Med; 1952 Mar; 52(5):569-71. PubMed ID: 14899720
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural representations of tumor-host relationships in mammary carcinoma; biologic and prognostic significance.
    BLACK MM; SPEER FD; OPLER SR
    Am J Clin Pathol; 1956 Mar; 26(3):250-65. PubMed ID: 13302171
    [No Abstract]   [Full Text] [Related]  

  • 4. ROENTGENOGRAPHY OF BREAST CANCER MODERATING CONCEPT OF "BIOLOGIC PREDETERMINISM".
    GERSHON-COHEN J; BERGER SM; KLICKSTEIN HS
    Cancer; 1963 Aug; 16():961-4. PubMed ID: 14050014
    [No Abstract]   [Full Text] [Related]  

  • 5. Do tumor size and biologic features interact with each other?! Which one is more important to affect breast cancer prognosis? Report of a breast cancer registry.
    Akrami M; Mojarad M; Ghoddusi Johari M; Zangouri V; Tahmasebi S; Talei A; Karimaghaei N
    Breast J; 2020 Nov; 26(11):2292-2294. PubMed ID: 33459441
    [No Abstract]   [Full Text] [Related]  

  • 6. Taxanes in combination with biologic agents for ovarian and breast cancers.
    Karki R; Seagle BL; Nieves-Neira W; Shahabi S
    Anticancer Drugs; 2014 May; 25(5):536-54. PubMed ID: 24300916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line chemotherapy with or without biologic agents for metastatic breast cancer.
    Andreetta C; Minisini AM; Miscoria M; Puglisi F
    Crit Rev Oncol Hematol; 2010 Nov; 76(2):99-111. PubMed ID: 20097088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma.
    Prasad R; Boland GP; Cramer A; Anderson E; Knox WF; Bundred NJ
    Cancer; 2003 Dec; 98(12):2539-46. PubMed ID: 14669271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemo-endocrine-immuno therapy with adriamycin, tamoxifen and OK-432 for advanced breast cancer].
    Sawai K; Takahashi S; Izumi H; Kato G; Takenaka A; Shinbata O; Tokuda H
    Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1315-20. PubMed ID: 6096466
    [No Abstract]   [Full Text] [Related]  

  • 10. [Carcinoma and the biologic rhythm of birth sequence].
    DIETRICH KF
    Med Monatsschr; 1951 Jun; 5(6):410-2. PubMed ID: 14862884
    [No Abstract]   [Full Text] [Related]  

  • 11. Bcl-2 expression on fine-needle aspirates from primary breast carcinoma: correlation with other biologic factors.
    Bozzetti C; Nizzoli R; Naldi N; Guazzi A; Camisa R; Bella MA; Cocconi G
    Cancer; 1999 Aug; 87(4):224-30. PubMed ID: 10455211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductal carcinoma in situ (DCIS) of the breast--a therapeutic dilemma.
    van Dongen JA; Bartelink H; Fentiman IS; Peterse JL
    Eur J Surg Oncol; 1987 Apr; 13(2):123-5. PubMed ID: 3030824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical test for evaluation of biosimilarity in variability of follow-on biologics.
    Hsieh TC; Chow SC; Liu JP; Hsiao CF; Chi E
    J Biopharm Stat; 2010 Jan; 20(1):75-89. PubMed ID: 20077250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some biologic problems of homogenized milk].
    DOCHAIN J
    Rev Med Liege; 1953 Feb; 8(4):146-51. PubMed ID: 13075308
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxicity Study of Cyclopentapeptide Analogues of Marine Natural Product Galaxamide towards Human Breast Cancer Cells.
    Lunagariya J; Liao X; Long W; Zhong S; Bhadja P; Li H; Zhao B; Xu S
    Oxid Med Cell Longev; 2017; 2017():8392035. PubMed ID: 29410736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas.
    Nizzoli R; Bozzetti C; Naldi N; Guazzi A; Gabrielli M; Michiara M; Camisa R; Barilli A; Cocconi G
    Cancer; 2000 Feb; 90(1):61-6. PubMed ID: 10692218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients.
    Gennari R; Curigliano G; Rotmensz N; Robertson C; Colleoni M; Zurrida S; Nolè F; de Braud F; Orlando L; Leonardi MC; Galimberti V; Intra M; Veronesi P; Renne G; Cinieri S; Audisio RA; Luini A; Orecchia R; Viale G; Goldhirsch A
    Cancer; 2004 Sep; 101(6):1302-10. PubMed ID: 15316944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary squamous cell carcinoma of the breast].
    Ligeti E; Brittig F
    Orv Hetil; 2005 Jun; 146(23):1257-60. PubMed ID: 15988921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon production in lymph nodes draining breast carcinoma and its augmentation by OK-432].
    Nakajima Y; Akimoto M; Kimura M; Matano S; Hirakawa H; Kasai M
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2766-71. PubMed ID: 2428312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic problems of evaluating vertebral metastasis from breast carcinoma with a higher degree of malignancy.
    Nishimura R; Nagao K; Miyayama H; Yasunaga T; Asao C; Matsuda M; Baba K; Matsuoka Y; Yamashita H; Fukuda M
    Cancer; 1999 Apr; 85(8):1782-8. PubMed ID: 10223573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.